Within the CBCT for Oral Cavity segmentation, the market is primarily divided by application. Diagnostic imaging accounts for the largest share, roughly 35 % of revenue, as dental practices adopt CBCT for comprehensive caries detection, periodontal bone loss assessment, and pathology identification. Surgical planning follows with an estimated 25 % contribution; clinicians rely on three‑dimensional reconstructions to map extractions, orthognathic procedures, and maxillofacial tumor resections, directly influencing equipment pricing and service contracts. Orthodontic assessment represents about 20 % of the market, driven by the need for precise tooth movement analysis and airway evaluation, which expands the installed base of mid‑range scanners. Implantology contributes 15 % as implant placement protocols increasingly mandate volumetric bone quality analysis, prompting higher‑value system sales. Finally, endodontic evaluation holds a modest 5 % share, reflecting niche adoption for complex root canal morphology studies. Collectively, these application segments dictate demand elasticity, guide R&D investment, and shape the overall market size for CBCT systems targeting the oral cavity.